Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KETALGIA
2024-518943-38-00Phase 3Completed
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of ketamine and magnesium sulfate in Cluster Headache (CH), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Change in weekly frequency of crisis over the period D7–D13 compared to the pre-treatment period. Started Dec 2024; status: completed.
02
Drugs
ketaminemagnesium sulfate
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on 2024-518943-38-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518943-38-00.